Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risperidone Depot (Microspheres) vs. Placebo in the Treatment of Subjects With Schizophrenia

NCT00253136 is registered in ClinicalTrials.gov with Janssen, LP as lead sponsor.

NCT NCT00253136
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00253136 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risperidone Depot (Microspheres) vs. Placebo in the Treatment of Subjects With Schizophrenia
Lead sponsor
Janssen, LP
Phase
Phase 3
Overall status
Completed
Start date
November 30, 1999
Completion date
December 31, 2000
Enrollment
458 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

psychotic disorders, schizophrenia